Exelixis, Inc. (EXEL)
72.78
+0.47
(+0.65%)
USD |
NASDAQ |
Nov 04, 16:00
73.80
+1.02
(+1.40%)
After-Hours: 17:15
Exelixis Total Return Price : 72.78 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 72.31 |
| November 02, 2026 | 70.13 |
| October 30, 2026 | 69.39 |
| October 29, 2026 | 66.20 |
| October 28, 2026 | 66.28 |
| October 27, 2026 | 65.35 |
| October 26, 2026 | 65.11 |
| October 23, 2026 | 64.53 |
| October 22, 2026 | 65.31 |
| October 21, 2026 | 64.58 |
| October 20, 2026 | 64.39 |
| October 19, 2026 | 62.68 |
| October 16, 2026 | 62.23 |
| October 15, 2026 | 62.83 |
| October 14, 2026 | 60.99 |
| October 13, 2026 | 59.51 |
| October 12, 2026 | 59.82 |
| October 09, 2026 | 59.86 |
| October 08, 2026 | 59.02 |
| October 07, 2026 | 58.44 |
| October 06, 2026 | 58.33 |
| October 05, 2026 | 58.85 |
| October 02, 2026 | 58.39 |
| October 01, 2026 | 57.94 |
| September 30, 2026 | 58.41 |
| Date | Value |
|---|---|
| September 29, 2026 | 58.65 |
| September 28, 2026 | 58.37 |
| September 25, 2026 | 58.16 |
| September 24, 2026 | 57.95 |
| September 23, 2026 | 56.73 |
| September 22, 2026 | 58.15 |
| September 21, 2026 | 57.22 |
| September 18, 2026 | 58.36 |
| September 17, 2026 | 58.49 |
| September 16, 2026 | 56.78 |
| September 15, 2026 | 56.90 |
| September 14, 2026 | 56.21 |
| September 11, 2026 | 56.12 |
| September 10, 2026 | 57.43 |
| September 09, 2026 | 58.33 |
| September 08, 2026 | 57.67 |
| September 04, 2026 | 59.01 |
| September 03, 2026 | 59.13 |
| September 02, 2026 | 58.53 |
| September 01, 2026 | 56.89 |
| August 31, 2026 | 54.64 |
| August 28, 2026 | 54.45 |
| August 27, 2026 | 55.26 |
| August 26, 2026 | 56.10 |
| August 25, 2026 | 56.72 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 57.13 |
| Alnylam Pharmaceuticals, Inc. | 160.91 |
| Cytokinetics, Inc. | 64.10 |
| Emergent BioSolutions, Inc. | 5.925 |
| Gilead Sciences, Inc. | 174.45 |